Radiation Oncology Journal10.3857/roj.2014.32.3.1632014323163Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinomaDa Hoon Jung, Mi-Sook Kim, Chul Koo Cho, Hyung Jun Yoo, Won Il Jang, Young Seok Seo, Eun Kyung Paik, Kum Bae Kim, Chul Ju Han, Sang Bum Kim,,
Radiotherapy and Oncology10.1016/j.radonc.2009.11.004201094147-52Stereotactic body radiotherapy for unresectable cholangiocarcinomaNeil Kopek, Marianne Ingerslev Holt, Anders Traberg Hansen, Morten Høyer,
Strahlentherapie und Onkologie10.1007/s00066-018-1367-22018195293-102Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic reviewJeongshim Lee, Won Sup Yoon, Woong Sub Koom, Chai Hong Rim,,
Cancer Control10.1177/10732748160230010320162316-11Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck CancersTobin Strom, Christian Wishka, Jimmy J. Caudell,
Radiotherapy and Oncology10.1016/j.radonc.2011.05.0162011992120-123Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experienceFrancesco Antonio Polistina, Rosabianca Guglielmi, Cristina Baiocchi, Paolo Francescon, Paolo Scalchi, Antonio Febbraro, Giorgio Costantin, Giovanni Ambrosino,
Radiation Oncology10.1186/1748-717x-7-67201271Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinomaBrandon M Barney, Kenneth R Olivier, Robert C Miller, Michael G Haddock,,
Radiotherapy and Oncology10.1016/s0167-8140(15)30363-72014111S99OC-0258: Outcomes and toxicity of stereotactic body radiotherapy for metastatic and recurrent central lung tumorsB. Mou, K.W. Merrell, D.A. Owen, K. Nelson, Y.I. Garces, K.R. Olivier,
Radiotherapy and Oncology10.1016/s0167-8140(04)82793-2200473S392926 poster Genetic profiling of distant recurrent glioblastoma after stereotactic radiotherapy: metastasis or second primary?,
Annals of Oncology10.1093/annonc/mdw376.70201627vi350A phase I dose escalation trial of stereotactic body radiotherapy and concurrent cisplatin for re-irradiation of unresectable, recurrent carcinomas of the head and neckJ. Caudell, A. Trotti, J. Kish, J. Russell,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2012.07.0372012843S12Stereotactic Body Radiation Therapy for Unresectable Intrahepatic and Hilar CholangiocarcinomaA. Mahadevan,